Please login to the form below

Not currently logged in

DigitasLBi appoints Alvaro Cabrera as chief strategy officer

He joins the agency from OgilvyOneNew York

DigitasLBi Alvaro CabreraDigitasLBi has appointed Alvaro Cabrera as chief strategy office.

Cabrera joins the Publicis agency from OgilvyOne New York, where he was most recently managing director and head of engagement planning.

In his new role Cabrera will report to Tony Weisman, CEO of DigitasLBi North America.

Weisman said: "Alvaro has the ability to find the key insights only human analysis uncovers from data.

“He is an award-winning strategist and creative thinker who takes that information and uses it to build the innovative strategies marketers need to engage consumers today."

Cabrera will work closely with Ronald Ng, chief creative officer, N.A, and Jason Kodish, global chief data scientist. He will also partner with the agency's global chief media officer Baba Shetty to deliver a consistent approach to strategy across teams and disciplines.

Cabrera said: "It truly is a wonder to see how data and technology are transforming the marketing landscape. Combining data, technology and storytelling to create the most compelling brand messages and experiences is something I find joy in - and having the chance to do so alongside Ronald and Jason only makes joining DigitasLBi that much more exciting."

23rd September 2015

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company

At Pegasus, we specialise in helping deliver healthy messages through integrated communication programmes. In fact, inspiring healthy decisions is all...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...